INTERNATIONAL PATENT: GUANGDONG PHARMACEUTICAL UNIVERSITY, 广东药科大学 FILES APPLICATION FOR "USE OF SEMILIQUIDAMBAR CATHAYENSIS H. T. CHANG. IN PREPARING DRUG FOR PREVENTING AND/OR TREATING LIVER INJURY"

GENEVA, Aug. 17 -- GUANGDONG PHARMACEUTICAL UNIVERSITY (No. 280, Waihuan East Road, Guangzhou Higher Education Mega Center, Panyu DistrictGuangzhou, Guangdong 510006), 广东药科大学 (中国广东省广州市番禺区广州大学城外环东路280号) filed a patent application (PCT/CN2024/128451) for "USE OF SEMILIQUIDAMBAR CATHAYENSIS H. T. CHANG. IN PREPARING DRUG FOR PREVENTING AND/OR TREATING LIVER INJURY" on Oct 30, 2024. With publication no. WO/2025/167214, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the Internat...